Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive global license agreement with Valneva SE (Nasdaq: ...

In five different studies, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such the substantial increase in antibiotic use due ...

Patients with Clostridioides difficile infection had different bacterial and fungal composition in their stool compared with that of uninfected patients, researchers found. Distinct species of fungus ...

Infection with the pathogen Clostridium difficile is a significant source of healthcare-associated infections and estimated to account for 12 percent of all HAIs in the U.S.1 C. diff infection is the ...

This study explores the effectiveness of toxin testing in predicting Clostridioides difficile infection (CDI) outcomes, revealing that patients with negative toxin results were less likely to ...

A new study from the University of Minnesota Medical School demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with ...

Paul Feuerstadt, MD, FACG, AGAF, discusses how testing for Clostridioides difficile is recommended for hospitalized patients or outpatients with new-onset, unexplained diarrhea who have risk factors ...

Scientists have successfully defeated a dangerous intestinal pathogen, Clostridium difficile, with a drug targeting its toxins rather than its life. C. difficile is responsible for more than 250,000 ...

Fecal Transplant Potential First-Line Treatment For C. Difficile Infection By Dennis Thompson HealthDay ReporterFRIDAY, June 20, 2025 (HealthDay News) — A fecal transplant performs as well as ...

It seemed to come out of nowhere — a virulent strain of bacteria called Clostridium difficile. It picked up that name because when it was first discovered, it was difficult to grow in the lab. C.